(Q39937711)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Treg suppress CTL responses upon immunization with HSP gp96 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Zhen Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Xinghui Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Xiaojun Zhang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Lizhao Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sheng Cao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Fusheng Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Songdong Meng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

1 November 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

3110-3120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19839010%20AND%20SRC:MED&resulttype=core&format=json

Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

Autologous renal cell cancer vaccines using heat shock protein-peptide complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

Generation of murine CTL by a hepatitis B virus-specific peptide and evaluation of the adjuvant effect of heat shock protein glycoprotein 96 and its terminal fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

Roles of heat-shock proteins in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Phylogenetic Conservation of Glycoprotein 96 Ability to Interact with CD91 and Facilitate Antigen Cross-Presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

The stress protein gp96 is not an activator of resting rat bone marrow-derived dendritic cells, but is a costimulator and activator of CD3+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Significant correlation between expression level of HSP gp96 and progression of hepatitis B virus induced diseases.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

The dual nature of specific immunological activity of tumor-derived gp96 preparations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

TLR4 hyperresponsiveness via cell surface expression of heat shock protein gp96 potentiates suppressive function of regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

"It is the antigen(s), stupid" and other lessons from over a decade of vaccitherapy of human cancer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Enhancing the potency of HBV DNA vaccines using fusion genes of HBV-specific antigens and the N-terminal fragment of gp96

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

HBcAg-specific CD4+CD25+ regulatory T cells modulate immune tolerance and acute exacerbation on the natural history of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8+ T lymphocytes in fulminant hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

HBV-specific peptide associated with heat-shock protein gp96

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Removal of endotoxin from recombinant protein preparations.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021

Identification of the N-terminal peptide binding site of glucose-regulated protein 94.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200939593

7 January 2021